Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02031718 · ClinicalTrials.gov registry record · NA
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone
A NA study of Acne Vulgaris, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT02031718: Completed NA study of Acne Vulgaris, sponsored by University of California, Davis.
NCT02031718 is a NA study of Acne Vulgaris that has completed, run by University of California, Davis. The registered enrollment target is 98 participants, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02031718, a NA study of Acne Vulgaris, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will develop and evaluate the efficacy of an Internet-based education program incorporating virtual coaching. For this study, the virtual coach will consist of online videos aimed at providing acne education and promoting behaviors that support healthy skin. The use of Web-based technologies and virtual coaching in acne-related patient education is novel, and may significantly improve clinical outcomes and quality of life in acne patients. We hypothesize that an interactive Internet-based education and counseling program will be more effective than Internet-based education alone in improving clinical outcomes and quality of life in acne patients.
Conditions Studied
Interventions
- BEHAVIORAL Virtual Counseling
Study Locations (1)
California
- University of California, Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT02031718 record still lists
NCT02031718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 274-participant average among 67 other Acne Vulgaris trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Acne Vulgaris appearing as the primary indexed condition, and to 1 intervention - of which Virtual Counseling is the first listed.
NCT02031718 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02031718 about?
NCT02031718 is a clinical study titled "Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone". This study will develop and evaluate the efficacy of an Internet-based education program incorporating virtual coaching. For this study, the virtual coach will consist of online videos aimed at providing acne education and promoting behaviors that support healthy skin. The use of Web-based technolog...
What is the current status of trial NCT02031718?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2014-01. Estimated completion is 2014-07.
What conditions does trial NCT02031718 study?
This clinical trial studies the following conditions: Acne Vulgaris.
What interventions are being tested in trial NCT02031718?
The interventions under investigation include: Virtual Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02031718?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02031718 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acne Vulgaris
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02031718's enrollment target sits among peer trials
98 39th of 67 higher than 29 of 67 other Acne Vulgaris trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acne Vulgaris trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Laser Treatment of Moderate to Severe Acne Vulgaris
ACTIVE NOT RECRUITING · NA
-
A Post Market Device Study for the Treatment of Acne
ACTIVE NOT RECRUITING · NA
-
A Clinical In-Use Evaluation to Assess the Tolerability and Efficacy of a Moisturizer on Acne Prone Skin
COMPLETED · NA
-
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris
COMPLETED · NA
-
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne
COMPLETED · NA
-
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia